Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Endometrial Neoplasms 13 Colorectal Neoplasms 12 Stomach Neoplasms 11 Lung Neoplasms 11 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Rectal Neoplasms 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Saline Solution 3 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 niraparib 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05775549 2024-09-20

FLAME

AstraZeneca

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡